Literature DB >> 4163976

Therapeutic hazards of phenylbutazone and oxyphenbutazone in polymyalgia rheumatica.

B Wadman, I Werner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1967        PMID： 4163976     DOI： 10.1016/s0140-6736(67)90444-8

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

1.  Temporal arteriography. A new technique for the investigation of giant cell arteritis and polymyalgia rheumatica.

Authors:  L A Gillanders; R W Strachan; D W Blair
Journal:  Ann Rheum Dis       Date:  1969-05       Impact factor: 19.103

2.  Polymyalgia rheumatica and associated arteritis: A review.

Authors:  M A Goodman; C M Pearson
Journal:  Calif Med       Date:  1969-12

3.  Temporal arteritis developing during indomethacin therapy of polymyalgia rheumatica.

Authors:  W M Easterbrook; D W Baxter; J R Martin
Journal:  Can Med Assoc J       Date:  1967-08-05       Impact factor: 8.262

4.  Polymyalgia rheumatica. Abrupt and gradual withdrawal of prednisolone treatment, clinical and laboratory observations.

Authors:  W Esselinckx; S M Doherty; A S Dixon
Journal:  Ann Rheum Dis       Date:  1977-06       Impact factor: 19.103

5.  Polymyalgia rheumatica. Assessment of disease activity using erythrocyte sedimentation rate and plasma viscosity.

Authors:  W Esselinckx; R C Bucknall; A S Dixon
Journal:  Ann Rheum Dis       Date:  1977-12       Impact factor: 19.103

6.  The ESR in the diagnosis and management of the polymyalgia rheumatica/giant cell arteritis syndrome.

Authors:  M E Ellis; S Ralston
Journal:  Ann Rheum Dis       Date:  1983-04       Impact factor: 19.103
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.